Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.55 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.55 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.55 |
| ▸ | HTR2B | P41595 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | SCN4A | P35499 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10031780 | 1.00 | ADORA3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL7387546 | 1.00 | ADORA3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL7600467 | 1.00 | ADORA3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL672415 | 1.00 | ADORA3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL7810245 | 1.00 | ADORA3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL5838534 | 0.95 | ABCC3 (0.55) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL4956494 | 0.89 | CYP3A4 (0.57) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL5373760 | 0.89 | ABCC3 (0.47) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL13536317 | 0.88 | ABCC3 (0.58) | ADORA3ABCC3ABCC4ABCB11PGR | |
| SCHEMBL30261823 | 0.88 | ABCC3 (0.65) | ADORA3ABCC3ABCC4ABCB11PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220380320-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME | GYEONGGIDO BUSINESS & SCIENCE ACCELERATOR (KR) | 2022-12-01 | — | — | US | disclosed |
| WO-2020159343-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME | 재단법인 경기도경제과학진흥원 | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220380320-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME | ACE, ACE2, SARS1 | ADORA3 1688/4885ABCC3 850/4885ABCC4 1261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.